Deerland Probiotics & Enzymes Hires Vice President of Sales-Americas, Expands Executive Team

KENNESAW, GA (November 18, 2020) – Deerland Probiotics and Enzymes has announced the hiring of a new vice president of sales-Americas as well as the creation of a new executive level position for product development and supply chain.

Michelle Cook has been named the company’s vice president of sales for the Americas region. Cook brings more than 25 years of experience leading sales teams in the OTC pharmaceutical and dietary supplement industries, most recently with DuPont Nutrition & Biosciences. She will oversee Deerland’s team of business development managers as they serve customers across the dietary supplement, food and beverage and pet nutrition industries.

With the addition of Michelle Cook as vice president of sales, Tod Burgess, who previously held the position for more than 20 years, has moved into the newly created role of vice president of product development and supply chain.  In this role, Burgess’s expertise will be harnessed to optimize the up-front product development process and supply chain continuity.

Scott Ravech, CEO, comments, “The addition of Michelle Cook to our staff along with Tod’s new role as vice president of product development and supply chain position demonstrates Deerland’s commitment to placing the best people in critical roles in order to provide maximum value for our customers.”

Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology.  The company offers a line of unique, clinically validated branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast®, Glutalytic® and Bifolac® probiotic strains.  Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement, food and beverage, sports nutrition, and companion animal markets. In addition to branded ingredients and customized formulations, Deerland offers full turnkey products for private label through its YourBrand® portfolio.  The company’s manufacturing services include bulk blends, capsules, stick packs and tablets, as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.deerland.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

skilled trades mentorship
Why the Modern Data Center Is Forcing Communities and Policymakers to Rethink Infrastructure
April 21, 2026

Data centers have moved from largely invisible digital infrastructure to a highly visible source of public debate as artificial intelligence accelerates demand for power, fiber, and compute capacity. The modern data center is now being built closer to population centers to support low-latency services, bringing critical infrastructure into direct contact with residential communities for…

Read More
Inside the Spot Freight Shift: How Manifold Is Simplifying a Fragmented Logistics Market
April 21, 2026

The freight market is in the midst of a notable shift. With national tender rejection rates approaching 14% by the end of Q1, freight conditions have shifted back in carriers’ favor, often coinciding with increased activity in the spot market. At the same time, logistics teams are juggling an increasingly fragmented ecosystem of portals, emails,…

Read More
healthcare 2026
Healthcare’s 2026 Reality: Growing Workforce Gaps, Tiered Access, and the Rise of AI Support
April 20, 2026

Healthcare systems are entering 2026 under mounting pressure. A growing, aging population and rising disease burden are colliding with persistent workforce shortages—highlighted by projections that new cancer diagnoses in the U.S. will surpass two million this year alone. The stakes are no longer theoretical: delays in care, limited specialist access, and widening disparities are…

Read More
Mental Health Care
Policy, AI, and New Funding Models Are Reshaping Mental Health Care Delivery
April 16, 2026

Mental health care isn’t a new problem—but it’s finally being treated like an urgent one. After years of being sidelined, the cracks in the system are becoming impossible to ignore: overstretched clinicians, long wait times, and entire communities without consistent access to care. In the U.S., the scale is striking—more than one in five…

Read More